- $89.13m
- -$77.83m
- CNY1.02bn
- 93
- 99
- 35
- 89
Annual income statement for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 219 | 532 | 945 | 986 | 1,018 |
Cost of Revenue | |||||
Gross Profit | 134 | 365 | 661 | 691 | 721 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 497 | 576 | 999 | 874 | 858 |
Operating Profit | -279 | -44.5 | -54.2 | 112 | 160 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -274 | -37 | -37.2 | 133 | 203 |
Provision for Income Taxes | |||||
Net Income After Taxes | -276 | -37.5 | -37.1 | 110 | 181 |
Net Income Before Extraordinary Items | |||||
Net Income | -276 | -37.5 | -37.1 | 110 | 181 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -276 | -48.3 | -37.1 | 110 | 181 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.22 | -0.213 | -0.139 | 0.406 | 0.661 |